Revvity, Inc. is a healthcare company.
Revvity, Inc. (RVTY) is expected to report earnings on Monday, October 26, 2026, before the open. Estimated release time 07:08 ET. Consensus EPS estimate is $1.28.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-08-04 | FY2026 Q3 | $1.21 | $1.41 | +16.5% | $711.00M |
| 2026-05-05 | FY2026 Q2 | $1.02 | $1.06 | +3.9% | $711.12M |
| 2026-02-02 | FY2025 Q4 | — | $0.87 | — | $772.06M |
| 2025-10-27 | FY2025 Q3 | $1.14 | $1.18 | +3.5% | $698.95M |
| 2025-07-28 | FY2025 Q2 | $1.14 | $1.18 | +3.5% | $720.28M |
| 2025-04-28 | FY2025 Q1 | $0.96 | $1.01 | +5.2% | $664.76M |
| 2025-01-31 | FY2024 Q4 | — | $0.78 | — | $729.37M |
| 2024-11-04 | FY2024 Q3 | $1.13 | $1.28 | +13.3% | $684.05M |
RVTY has beaten consensus EPS in 6 of its last 8 reported quarters.
Highlights from RVTY's Aug 4 report: EPS of $1.41 — a big beat vs the $1.21 estimate (+17%); revenue of $711M — in line with the $703M consensus.
RVTY pays a quarterly dividend, currently yielding 0.22%.
| Ex-dividend date | Amount | Paid |
|---|---|---|
| 2026-10-23 | $0.07 | 2026-11-13 |
| 2026-07-17 | $0.07 | 2026-08-07 |
| 2026-04-17 | $0.07 | 2026-05-08 |
| 2026-01-16 | $0.07 | 2026-02-06 |
| 2025-10-17 | $0.07 | 2025-11-07 |
| 2025-07-18 | $0.07 | 2025-08-08 |